The global cell surface markers market is
expected to rise at a strong 7.8% CAGR over the forecast period from 2022 to
2030, according to the latest research report from Market Research Future
(MRFR). The global cell surface markers market is analyzed in great detail in
the report, which provides a comprehensive overview of the market’s historical
growth trajectory, current condition, and future growth prospects. Major
players and key segments in the global cell surface markers market are also profiled in the report in order to
provide readers with a complete overview of the market. The global cell surface
markers market was valued at USD 498 million in 2017, according to the research
report.
The cell surface markers market refers to
the market for tools and technologies used for the identification and analysis
of specific markers on the surface of cells. These markers can be used to
distinguish different cell types or to monitor changes in cell populations
under different conditions, such as in response to a disease or a drug
treatment.
Cell surface markers are a vital way of
identifying certain types of cells, such as T cells, B cells, and NK (natural
killer) cells. As a result, they are widely used in clinical research
applications in the healthcare industry. Cancer is one of the key applications
of cell surface markers. This is likely to be a major driver for the cell
surface markers market over the forecast period, as cancer research is likely
to remain top of the agenda for most players in the clinical research sector.
Hematology research is also likely to account for considerable usage of cell
surface markers in the coming years, leading to a growing demand from the cell
surface markers market over the forecast period. Increasing demand from the
medical research industry is likely to be a major driver for the cell surface
markers market over the forecast period.
Competitive
Analysis:
The global cell surface marker market players include Bio-Rad Laboratories
Inc., Siemens Healthcare Private Limited, Beckman Coulter Inc., Nihon Kohden
Corporation, F. Hoffman-La Roche Ltd., BD, Abcam plc, Qiagen, Thermo Fisher
Scientific, Abbott, Danaher, GenScript, Merck KGaA, BioLegend Inc., Cell Signaling
Technology Inc., and Bio-Techne.
In August 2019, researchers at Monash
University discovered a protein that suppresses the release of natural killer
(NK) cells in response to cancer. The researchers found that suppressing this
protein can turbocharge an individual’s ability to fight cancer.
Segmentation:
The global cell surface marker market is
segmented on the basis of product, source, cell type, application, and region.
By product, the global cell surface marker
market is segmented into antibodies and PCR arrays.
By source, the global cell surface markers
market is segmented into mice, rats, and others.
By cell type, the global cell surface marker market is segmented into T
cells, B cells, and NK cells.
By application, the market is segmented into
research, clinical, and others. The research segment is further sub-segmented
into stem cell and immunology, whereas the clinical segment is further
sub-segmented into oncology and hematology. The research segment is expected to
hold the largest share in the global cell surface markers market over the
forecast period due to the growing demand for cell surface markers in clinical
research applications. On the other hand, the clinical application segment is
likely to exhibit the highest CAGR over the forecast period.
Regional Analysis:
North America dominates the global cell
surface markers market due to the strong presence of the clinical research
sector in the region’s developed economies. The growing presence of medical
research entities in North America is likely to remain a major driver for the
cell surface markers market in the region over the forecast period. Medical
research is a big deal in North America, as most of the leading players in the
medical research sector are present in the region. The presence of top players
has elevated the medical research sector in North America to above other
regions. The strong presence of cellular researchers in North America,
particularly in the fields of cancer research and hematological research, is
likely to be a major driver for the cell surface marker market in North
America.
Europe is also a major region for the
global cell surface markers market and is likely to exhibit progressive growth
over the forecast period.
Asia Pacific is likely to exhibit the fastest
growth in the global cell surface marker market over the forecast period due to
the growing demand for cell surface marker technology in the developing
clinical research sectors in China, India, and Australia.
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment